Ebola prevention pill study halted before it began
NCT ID NCT06682234
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 23 times
Summary
This study aimed to test the safety and effectiveness of the drug obeldesivir in preventing filovirus diseases like Ebola after a known or suspected exposure. It was designed for people who had high-risk contact with the virus within the past 21 days. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FILOVIRUS DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.